Showing results (2181-2190 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|October 21, 2015
Cost-Effectiveness of a Biopsy-Based 8-Protein Prostate Cancer Prognostic Assay to Optimize Treatment Decision Making in Gleason 3 + 3 and 3 + 4 Early Stage Prostate CancerJoshua A Roth, Scott D Ramsey, Josh J Carlson
The Oncologist|February 3, 2016
Contemporary Management of Borderline Resectable and Locally Advanced Unresectable Pancreatic CancerWalid L Shaib, Andrew Ip, Kenneth Cardona, et al.
The Oncologist|February 12, 2016
Occupational Therapy for Adults With Cancer: Why It MattersMackenzi Pergolotti, Grant R Williams, Claudine Campbell, et al.
The Oncologist|February 12, 2016
Predictive and Prognostic Role of Tumor-Infiltrating Lymphocytes for Early Breast Cancer According to Disease Subtypes: Sensitivity Analysis of Randomized Trials in Adjuvant and Neoadjuvant SettingLuisa Carbognin, Sara Pilotto, Rolando Nortilli, et al.
The Oncologist|February 12, 2016
Impact of a Patient Blood Management Program and an Outpatient Anemia Management Protocol on Red Cell Transfusions in Oncology Inpatients and OutpatientsIrwin Gross, Kevin M Trentino, Astrid Andreescu, et al.
The Oncologist|February 28, 2016
Responding to Acute Care Needs of Patients With Cancer: Recent Trends Across ContinentsAlison Young, Ernie Marshall, Monika Krzyzanowska, et al.
The Oncologist|February 28, 2016
Prognostic Implication of the Absolute Lymphocyte to Absolute Monocyte Count Ratio in Patients With Classical Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine or Equivalent RegimensTheodoros P Vassilakopoulos, Maria N Dimopoulou, Maria K Angelopoulou, et al.
The Oncologist|February 28, 2016
A Systematic Review of Adherence to Oral Antineoplastic TherapiesJoseph A Greer, Nicole Amoyal, Lauren Nisotel, et al.
The Oncologist|September 30, 2015
The Frequency, Characteristics, and Outcomes Among Cancer Patients With Delirium Admitted to an Acute Palliative Care UnitMaxine de la Cruz, Viraj Ransing, Sriram Yennu, et al.
The Oncologist|August 26, 2015
A Randomized, Multicenter, Phase II Study of Cetuximab With Docetaxel and Cisplatin as Induction Chemotherapy in Unresectable, Locally Advanced Head and Neck CancerKeun-Wook Lee, Youngil Koh, Sung-Bae Kim, et al.
Pageof 571